Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 33,323Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3AbbVie Inc

02 2Aspen API

03 6Aspen Pharmacare Holdings

04 2Pharmathen SA

05 8Accord healthcare

06 2Aurobindo Pharma Limited

07 1Bharat Parenterals Limited

08 2Caplin Point Laboratories Limited

09 4Cristalia Produtos Quimicos Farma. Ltda

10 8Farbe Firma

11 1Fresenius Kabi AB Brunna

12 3Fresenius Kabi USA

13 1Fresenius SE & Co. KGaA

14 3GLAND PHARMA LIMITED

15 4GSK

16 3Hainan Poly Pharm

17 5Health Biotech

18 4Hikma Pharmaceuticals

19 3Hospira, Inc.

20 5Jiangsu Hengrui Medicine

21 1Kalcex

22 2LABORATORIOS NORMON SA

23 1MS Pharma

24 3Meitheal Pharmaceuticals

25 2Montage Laboratories

26 2Naprod Life Sciences

27 1Omega Laboratories Limited

28 1Pfizer Inc

29 2Piramal Pharma Solutions

30 1Pluviaendo

31 3Rajasthan Antibiotics

32 2Reig Jofre

33 3Safeline Pharmaceuticals

34 3Sagent Pharmaceuticals

35 3Sandoz B2B

36 3Somerset Pharmaceuticals Inc

37 2Themis Medicare

38 3Viatris

39 1Zhejiang Xianju Pharmaceutical Co. Ltd

40 3Zydus Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

CISATRACURIUM BESYLATE

Brand Name : NIMBEX

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1995-12-15

Application Number : 20551

Regulatory Info : DISCN

Registration Country : USA

Abbvie Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAspen API. More than just an API™

Regulatory Info : Authorized

Registration Country : Spain

Cisatracurium Besylate

Brand Name : Nimbex

Dosage Form : Injectable Solution/Infusion

Dosage Strength : 5MG

Packaging :

Approval Date : 2002-09-11

Application Number : 61199

Regulatory Info : Authorized

Registration Country : Spain

Aspen API Comapny Banner

03

Cisatracurium

Brand Name : Nimbex

Dosage Form : Solution For Injection

Dosage Strength : 5mg/2.5ml

Packaging :

Approval Date : 15/01/1997

Application Number : 53677

Regulatory Info : Allowed

Registration Country : Switzerland

Aspen API Comapny Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info : EU Approved

Registration Country : Greece

Cisatracurium Besylate

Brand Name :

Dosage Form : Solution For Injection

Dosage Strength : 2MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

05

CISATRACURIUM BESYLATE

Brand Name : NIMBEX PRESERVATIVE FREE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : EQ 10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1995-12-15

Application Number : 20551

Regulatory Info : DISCN

Registration Country : USA

Abbvie Company Banner

06

CISATRACURIUM BESYLATE

Brand Name : NIMBEX PRESERVATIVE FREE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1995-12-15

Application Number : 20551

Regulatory Info : DISCN

Registration Country : USA

Abbvie Company Banner

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAspen API. More than just an API™

Regulatory Info : Cancelled

Registration Country : Spain

Cisatracurium Besylate

Brand Name : Nimbex

Dosage Form : Injectable Solution/Infusion

Dosage Strength : 2MG

Packaging :

Approval Date : 1996-11-01

Application Number : 61200

Regulatory Info : Cancelled

Registration Country : Spain

Aspen API Comapny Banner

08

Cisatracurium

Brand Name : Nimbex

Dosage Form : Solution For Injection

Dosage Strength : 20mg/10ml

Packaging :

Approval Date : 15/01/1997

Application Number : 53677

Regulatory Info : Allowed

Registration Country : Switzerland

Aspen API Comapny Banner

09

Cisatracurium

Brand Name : Nimbex 2 mg/ml (2,5 ml)

Dosage Form : INJ

Dosage Strength : 2mg/ml

Packaging : 2.5X5mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

10

Cisatracurium

Brand Name : Nimbex 2 mg/ml (5 ml)

Dosage Form : INJ

Dosage Strength : 2mg/ml

Packaging : 5X5mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

11

Cisatracurium

Brand Name : Nimbex 2 mg/ml (10 ml)

Dosage Form : INJ

Dosage Strength : 2mg/ml

Packaging : 10X5mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

12

Cisatracurium

Brand Name : Nimbex 5

Dosage Form : INJ

Dosage Strength : 5mg/ml

Packaging : 30X1mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

13

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info : EU Approved

Registration Country : Greece

Cisatracurium Besylate

Brand Name :

Dosage Form : Solution For Injection

Dosage Strength : 5MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

14

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

CISATRACURIUM BESYLATE

Brand Name : CISATRACURIUM BESYLATE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : EQ 2MG BASE/ML

Packaging :

Approval Date : 2022-06-28

Application Number : 203078

Regulatory Info : RX

Registration Country : USA

blank

15

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

CISATRACURIUM BESYLATE

Brand Name : CISATRACURIUM BESYLATE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : EQ 2MG BASE/ML

Packaging :

Approval Date : 2020-11-06

Application Number : 201836

Regulatory Info : RX

Registration Country : USA

blank

16

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

CISATRACURIUM BESYLATE

Brand Name : CISATRACURIUM BESYLATE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : EQ 10MG BASE/ML

Packaging :

Approval Date : 2020-11-06

Application Number : 201836

Regulatory Info : RX

Registration Country : USA

blank

17

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

CISATRACURIUM BESYLATE

Brand Name : CISATRACURIUM BESYLATE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : EQ 2MG BASE/ML

Packaging :

Approval Date : 2020-11-06

Application Number : 201851

Regulatory Info : RX

Registration Country : USA

blank

18

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

CISATRACURIUM BESYLATE

Brand Name : CISATRACURIUM BESYLATE PRESERVATIVE FREE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : EQ 2MG BASE/ML

Packaging :

Approval Date : 2012-02-03

Application Number : 200154

Regulatory Info : RX

Registration Country : USA

blank

19

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

CISATRACURIUM BESYLATE

Brand Name : CISATRACURIUM BESYLATE PRESERVATIVE FREE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : EQ 10MG BASE/ML

Packaging :

Approval Date : 2012-02-03

Application Number : 200154

Regulatory Info : RX

Registration Country : USA

blank

20

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

CISATRACURIUM BESYLATE

Brand Name : CISATRACURIUM BESYLATE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : EQ 2MG BASE/ML

Packaging :

Approval Date : 2012-02-03

Application Number : 200159

Regulatory Info : RX

Registration Country : USA

blank